PT - JOURNAL ARTICLE AU - George Stojan AU - Jessica Li AU - Matthew Budoff AU - Armin Arbab-Zadeh AU - Michelle A Petri TI - High-risk coronary plaque in SLE: low-attenuation non-calcified coronary plaque and positive remodelling index AID - 10.1136/lupus-2020-000409 DP - 2020 Jul 01 TA - Lupus Science & Medicine PG - e000409 VI - 7 IP - 1 4099 - http://lupus.bmj.com/content/7/1/e000409.short 4100 - http://lupus.bmj.com/content/7/1/e000409.full SO - Lupus Sci Med2020 Jul 01; 7 AB - Background Positive remodelling index and presence of low-attenuation non-calcified plaque (LANCP) are characteristic vessel changes in unstable coronary plaques. We sought to characterise these high-risk plaque features in patients with systemic lupus erythematosus (SLE) and to compare them with controls.Methods A total of 72 patients who satisfied the SLICC classification criteria for SLE had coronary CT angiography (CCTA) studies, 30 of which had follow-up CCTA, as screening for occult coronary atherosclerotic disease in asymptomatic individuals. A total of 100 consecutive controls with no known history of lupus, heart disease or revascularisation who had two coronary CT angiograms at least 1 year apart were included in the study. These were asymptomatic patients referred by their primary physicians for screening of coronary artery disease and the screening interval was decided by the primary physicians. The methodology for image acquisition was identical.Results LANCP burden at baseline was significantly greater in patients with SLE compared with controls. LANCP volume was significantly greater in patients over 60 years of age (p<0.05) and in those with current prednisone dose >10 mg/day. LANCP burden remained stable over follow-up. There were no significant differences in remodelling index compared with controls.Conclusion This is the first study describing high-risk CCTA features of coronary plaque in patients with SLE. Both LANCP and positive remodelling are common in SLE. These characteristic vessel changes may identify patients with SLE at increased risk of cardiovascular events and those in need for more frequent cardiac monitoring.